Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | AMGN | REGN | ||
| Company | Vertex Pharmaceutic | Amgen Inc | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 393.52 | 265.72 | 881.72 | ||
| High | 399.68 | 271.68 | 887.48 | ||
| Low | 393.49 | 265.72 | 875.22 | ||
| Last | 397.48 | 269.98 | 883.20 | ||
| Change | -0.22 | +0.60 | -7.48 | ||
| % Change | -0.06% | +0.22% | -0.84% | ||
| Volume | 682,400 | 2,436,900 | 505,600 | ||
| 20-Day Average Volume | 943,625 | 2,156,940 | 457,100 | ||
| Previous Close | 397.70 | 269.38 | 890.68 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 401.28 | 269.99 | 918.54 | ||
| 20-Day Raw Stochastic | 21.25% | 40.03% | 8.40% | ||
| 20-Day Relative Strength | 42.53% | 45.47% | 33.09% | ||
| Weighted Alpha | +14.78 | +9.45 | +9.82 | ||
| Today's Opinion | 8% Buy | 72% Sell | 8% Sell | ||
| Previous Opinion | 8% Buy | 72% Sell | 8% Buy | ||
| Last Month's Opinion | 56% Buy | 40% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.81% since 04/19/24 | +0.39% since 04/19/24 | -1.52% since 04/19/24 | ||
| Low | 393.00 on 04/25/24 | 265.72 on 04/26/24 | 875.22 on 04/26/24 | ||
| High | 406.86 on 04/23/24 | 274.86 on 04/24/24 | 915.70 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | -5.01% since 03/26/24 | -4.18% since 03/26/24 | -8.34% since 03/26/24 | ||
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | ||
| High | 421.45 on 04/01/24 | 288.57 on 03/28/24 | 976.75 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | -7.60% since 01/26/24 | -13.40% since 01/26/24 | -6.05% since 01/26/24 | ||
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | ||
| High | 448.40 on 01/30/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +10.02% since 10/26/23 | +0.10% since 10/26/23 | +11.51% since 10/26/23 | ||
| Low | 341.90 on 11/16/23 | 249.70 on 10/31/23 | 769.19 on 10/27/23 | ||
| High | 448.40 on 01/30/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 102,732,288 | 144,810,784 | 96,941,800 | ||
| Shares Outstanding, K | 258,459 | 536,376 | 109,762 | ||
| Annual Sales | 9,869,200,000 | 28,190,000,000 | 13,117,200,000 | ||
| Annual Net Income | 3,619,600,000 | 6,717,000,000 | 3,953,600,000 | ||
| Last Quarter Sales | 2,517,700,000 | 8,196,000,000 | 3,434,300,000 | ||
| Last Quarter Net Income | 968,800,000 | 767,000,000 | 1,159,600,000 | ||
| 60-Month Beta | 0.35 | 0.58 | 0.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.20 on 02/05/24 | 4.71 on 02/06/24 | 11.86 on 02/02/24 | ||
| Latest Earnings Date | 05/06/24 | 05/02/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 29.59 | 14.44 | 23.70 | ||